Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-20

Clinical Trial Update: Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets [Phase 3]

View source ↗

Summary

A Phase 3 pediatric trial comparing Advair Diskus (fluticasone propionate/salmeterol) with montelukast chewable tablets for asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADVAIR DISKUS (fluticasone propionate and salmeterol)
  • Montelukast chewable tablets (montelukast)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED